Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study.
Gramatzki D, Roth P, Rushing EJ, Weller J, Andratschke N, Hofer S, Korol D, Regli L, Pangalu A, Pless M, Oberle J, Bernays R, Moch H, Rohrmann S, Weller M.
Gramatzki D, et al. Among authors: pangalu a.
Ann Oncol. 2018 Jun 1;29(6):1431-1436. doi: 10.1093/annonc/mdy106.
Ann Oncol. 2018.
PMID: 29617713
Free article.